A New Paradigm: Using PARP Inhibitors to Treat HER2+ Breast Cancer

Grant

Date/time Interval

  • August 1, 2018 - July 31, 2021
  • Total Award Amount

  • 450000.00
  • Direct Costs

  • 360000.00
  • Sponsor Award Id

  • CCR17483682
  • Contributor

  • Eddy Yang M.D., Ph.D.   Investigator  
  • Edward Acosta Pharm.D.   Investigator  
  • Erica Stringer-Reasor M.D.   Principal Investigator